Patent · US Active

MiRNA biomarkers of lung disease

US8735074B2 · kind B2 · utility

5Cited by

5References

37Claims

0Family size

Assignee

ASURAGEN, INC. · US

Inventors

Elizabeth Mambo · Austin, US
David Brown · Brighton, US
Alex Adai · Austin, US
Tiffany Sanford · Round Rock, US
Stephanie Volz · Austin, US
Ashish Choudhary · Austin, US

Key dates

Filing date	Aug 27, 2010
Grant date	May 27, 2014
Priority date	—
Expiry date	Feb 20, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing lung disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.